The cost of COPD: results from the SIRIBO study

L. G. Mantovani, S. Mannino, C. F. Donner, R. M. Busca, M. C. J. M. Sturkenboom (Milan, Segrate, Verona, Italy; Rotterdam, The Netherlands)

Source: Annual Congress 2002 - Prevalence and costs of COPD
Session: Prevalence and costs of COPD
Session type: Thematic Poster Session
Number: 832
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. G. Mantovani, S. Mannino, C. F. Donner, R. M. Busca, M. C. J. M. Sturkenboom (Milan, Segrate, Verona, Italy; Rotterdam, The Netherlands). The cost of COPD: results from the SIRIBO study. Eur Respir J 2002; 20: Suppl. 38, 832

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Direct cost analysis of COPD patients: A 1 year follow-up study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Characteristics of COPD patients with repeated exacerbations: preliminary results from the PRE-SPIRO survey
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008

GOLD classification of COPD and subsequent mortality: findings from a cohort study
Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment
Year: 2004


Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


The cost analysis of our COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006

The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008


Persistence to COPD therapies and impact on exacerbations: a French claims data study
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018




The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


Preliminary results of relationship between appetite and clinical presentation of COPD patients in AERIS study
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study
Source: International Congress 2018 – COPD management
Year: 2018


DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT)
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018


The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK)
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020




Worldwide under-diagnosis of COPD: results from the bold study
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009

A prediction model for exacerbations in patients with COPD generated in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2017 – Primary care management of asthma and COPD
Year: 2017


NIV after acute exacerbation of COPD: results from the Dutch multicentre study
Source: International Congress 2015 – Long-term non-invasive ventilation (NIV) in COPD
Year: 2015



Real-life COPD patients compared to large trial populations: An UNLOCK external validity study
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013

Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


The impact of comorbidities on mortality in COPD, report from the OLIN COPD study.
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018

Prevalence of COPD: updated meta-analysis results
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007


The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008